Chart: FDA's ANDA Approvals

FDA's ANDA Approvals
Applicant	Active Ingredients	Number	Date Approved
Cypress	Ranitidine HCl, EQ 15 mg base/mL syrup	78-684	8/27/2009
Hikma	Cephalexin, EQ 125 mg base/5 mL and EQ 250 mg base/5 mL oral suspension	65-444	8/28/2009
Actavis Totowa	Bicalutamide, 50 mg tabs.	78-634	8/28/2009
Watson	Levonorgestrel, 0.75 mg tabs.	78-665	8/28/2009
Wockhardt	Cetirizine HCl, 5 mg/5 mL syrup	78-757	8/28/2009
Hikma Farmaceutica	Benztropine mesylate, 1 mg/mL inj.	90-287	8/31/2009
Barr	Phentermine HCl, 37.5 mg tabs.	90-470	8/31/2009
Hospira	Heparin sodium, 1,000 units/mL, 5,000 units/mL and 10,000 units/mL inj.	90-571	8/31/2009
Watson	Ethinul estradiol/norethindrone acetate, 0.02 mg/1 mg tabs	78-267	9/1/2009
Tentative Approvals
Cipla	Irbesartan, 75 mg, 150 mg and 300 mg tabs.	77-205	8/31/2009